Author:
Wu Chenglin,Xi Cong,Tong Junhua,Zhao Jing,Jiang Hualiang,Wang Jiang,Wang Yiping,Liu Hong
Funder
National Program on Key Basic Research Project of China
National Natural Science Foundation
National Science & Technology Major Project Key New Drug Creation and Manufacturing Program
Strategic Priority Research Program of the Chinese Academy of Sciences
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference37 articles.
1. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015;Roth;J Am Coll Cardiol,2017
2. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017
3. PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells;Lagace;Curr Opin Lipidol,2014
4. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia;Abifadel;Nat Genet,2003
5. Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote;Zhao;Am J Hum Genet,2006
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献